June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Hypoxia Inducible Factor-1 Upregulates the Expression of Plasminogen Activator Inhibitor-1 in Retinal Endothelial Cells to Promote their Survival in Proliferative Diabetic Retinopathy Patients
Author Affiliations & Notes
  • Syed Junaid Hassan
    Wilmer Eye Institute, Johns Hopkins School Of Medicine, Clarksville, MD
  • Savalan Babapoor
    Wilmer Eye Institute, Johns Hopkins School Of Medicine, Clarksville, MD
  • Kathleen Josephine Jee
    Wilmer Eye Institute, Johns Hopkins School Of Medicine, Clarksville, MD
  • Brooks Puchner
    Wilmer Eye Institute, Johns Hopkins School Of Medicine, Clarksville, MD
  • Monika Deshpande
    Wilmer Eye Institute, Johns Hopkins School Of Medicine, Clarksville, MD
  • Gregg L Semenza
    Wilmer Eye Institute, Johns Hopkins School Of Medicine, Clarksville, MD
  • Silvia Montaner
    University of Maryland, School of Medicine, Baltimore, MD
  • Akrit Sodhi
    Wilmer Eye Institute, Johns Hopkins School Of Medicine, Clarksville, MD
  • Footnotes
    Commercial Relationships Syed Hassan, None; Savalan Babapoor, None; Kathleen Jee, None; Brooks Puchner, None; Monika Deshpande, None; Gregg Semenza, None; Silvia Montaner, None; Akrit Sodhi, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 4282. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Syed Junaid Hassan, Savalan Babapoor, Kathleen Josephine Jee, Brooks Puchner, Monika Deshpande, Gregg L Semenza, Silvia Montaner, Akrit Sodhi; Hypoxia Inducible Factor-1 Upregulates the Expression of Plasminogen Activator Inhibitor-1 in Retinal Endothelial Cells to Promote their Survival in Proliferative Diabetic Retinopathy Patients. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):4282. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Diabetic retinopathy (DR) is the most common diabetic microvascular complication. Damage to the retinal vasculature from sustained hyperglycemia ultimately leads to retinal ischemia, resulting in stabilization of the transcription factor hypoxia inducible factor (HIF)-1α and upregulation of the expression of angiogenic factors that promote the development of neovascularization (NV). This heralds the progression from non-proliferative to proliferative DR (PDR). The introduction of therapies targeting a HIF-1-regulated angiogenic mediator, vascular endothelial growth factor (VEGF), has transformed the treatment of diabetic macular edema. However, inhibition of this potent endothelial cell (EC) survival factor alone is not adequate for treating patients with PDR. Here we explore additional HIF-1-regulated EC survival factors that may contribute to the development and progression of retinal NV in PDR patients who do not respond adequately to anti-VEGF therapy.

Methods: Johns Hopkins School of Medicine Institutional Review Board approval was obtained to collect aqueous fluid (AF) and vitreous biopsies from patients undergoing intraocular surgery. Levels of VEGF were measured using ELISA. Angiogenic potential of AF was measured using tubule formation assay. A multiplex ELISA angiogenesis array was performed on AF from PDR patients with low VEGF levels but high angiogenic potential. Expression of angiogenic factors was confirmed by qPCR and ELISA in ECs in vitro and in the oxygen induced retinopathy model in vivo. Cell survival was measured using the MTS assay. Expression of angiogenic factors was confirmed in vitreous biopsies from PDR patients.

Results: We observed elevated levels of plasminogen activator inhibitor-1 (PAI-1) in AF from PDR patients with low VEGF levels but high angiogenic potential. PAI-1 mRNA expression was upregulated by HIF-1 in hypoxic ECs in vitro and the ischemic retina in vivo. Secretion of PAI-1 by hypoxic ECs cells was necessary and sufficient to promote EC survival. Increased expression of PAI-1 was confirmed in vitreous biopsies from PDR patients.

Conclusions: PAI-1 is a HIF-1-regulated secreted factor that promotes EC survival in PDR. We propose that PAI-1 is a good therapeutic target for the treatment of retinal NV in diabetic patients.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×